ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Strategy lagged behind the benchmark in the quarter due to the decline in consumer staples and health care, which was somewhat offset by strength in financials and industrials. […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Mirum Pharmaceuticals in a research note issued on Tuesday, January 9th. HC Wainwright analyst E. Arce now expects that the company will post earnings per share of $3.37 for the year, […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of Mirum Pharmaceuticals stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the transaction, the insider now owns 105,254 shares of the company’s stock, valued […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) SVP Jolanda Howe sold 528 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $28.04, for a total transaction of $14,805.12. Following the completion of the transaction, the senior vice president now directly […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) insider Lara Longpre sold 1,019 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $28.04, for a total transaction of $28,572.76. Following the sale, the insider now directly owns 105,254 shares of the company’s stock, […]